INDICATION:  [ ] year-old [ ] patient with [ ].

RADIOPHARMACEUTICAL:  F18-FDG.

DOSE:  [] mCi.

BLOOD GLUCOSE: [] mg/dL.

TECHNIQUE:  Approximately 60 minutes following IV tracer administration, positron emission tomography was performed from the base of the skull through the pelvis.  Non-contrast helical CT imaging was performed over the same range without breath-hold for attenuation correction of PET images and anatomic correlation, but not for primary interpretation as it is not of standard diagnostic quality.
 
COMPARISON: []

FINDINGS:

HEAD AND NECK:  There is no FDG-avid disease or significant lymphadenopathy in the imaged portions of the head and the neck.
 
CHEST:  There is no FDG-avid disease in the chest.  There is no axillary, mediastinal, or hilar lymphadenopathy.  There is no pleural or pericardial effusion.  There is no air-space disease or suspicious lung nodule.
 
ABDOMEN/PELVIS:  Below the diaphragm, tracer is distributed physiologically in the gastrointestinal and genitourinary tracts. There is no significant lymphadenopathy and no FDG-avid disease.
 
MUSCULOSKELETAL:  There is no FDG-avid or destructive bone lesion.
 
IMPRESSION:
 
There is no definite evidence of recurrent FDG-avid disease.
 
END OF IMPRESSION:

